top of page

NEWS & BLOGS
Blog: Blog2


FDA approves Pluvicto for metastatic castration-resistant prostate cancer
Mar 24 2022 On March 23, 2022, the Food and Drug Administration approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan, Advanced...
Provision Consulting Group
Mar 24, 20222 min read
20


FDA, Mercury Poisoning Linked to Skin Products
Mar 23 2022 The U.S. Food and Drug Administration cautions that you should avoid skin creams, beauty and antiseptic soaps, and lotions...
Provision Consulting Group
Mar 23, 20223 min read
37


Proposed Rule: Quality System Regulation Amendments FAQs
Mar 21 2022 On February 23, 2022, the FDA issued a proposed rule to amend the device current good manufacturing practice (CGMP)...
Provision Consulting Group
Mar 21, 20223 min read
39


The Generic Drug Approval Process
Mar 17 2022 FDA requires a generic drug company to produce enough data to demonstrate the company can make a drug that can be...
Provision Consulting Group
Mar 17, 20225 min read
26


FDA, How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated
Mar 16 2022 The law does not require cosmetic products and ingredients, other than color additives, to have FDA approval before they go...
Provision Consulting Group
Mar 16, 20226 min read
59


FDA Approves First Generic of Symbicort to Treat Asthma and COPD
Mar 15 2022 On March 15 2022, The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol...
Provision Consulting Group
Mar 15, 20222 min read
22


FDA, FY 2022 OTC Monograph Drug User Fee(OMUFA)
Mar 14 2022 On March 14, 2022, FDA announced the rates for over-the-counter (OTC) monograph drug user fees for fiscal year (FY) 2022. OTC...
Provision Consulting Group
Mar 14, 20221 min read
26


FDA, guidance of Pre-Submission
We want to give you some advice on Pre-Submission which leads to successful FDA approval. FDA offers a Pre-submission program and...
Provision Consulting Group
Mar 14, 20222 min read
71


FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments
Mar 08 2022 March 01 2022, the U.S. Food and Drug Administration issued three final guidances to industry regarding cancer clinical...
Provision Consulting Group
Mar 8, 20223 min read
30


FDA, CDER's Drug Approvals and Programming to Speed Therapeutic Development
Mar 07 2022 FDA I Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research A rare disease is any disease that...
Provision Consulting Group
Mar 7, 20223 min read
25
bottom of page